PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SEEL vs. GHRS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SEEL and GHRS is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

SEEL vs. GHRS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Seelos Therapeutics, Inc. (SEEL) and GH Research PLC (GHRS). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-100.00%
-36.38%
SEEL
GHRS

Key characteristics

Fundamentals

Market Cap

SEEL:

$214.97K

GHRS:

$440.16M

EPS

SEEL:

$351.04

GHRS:

-$0.79

Total Revenue (TTM)

SEEL:

$1.61M

GHRS:

$80.00K

Gross Profit (TTM)

SEEL:

$1.56M

GHRS:

-$156.00K

EBITDA (TTM)

SEEL:

-$17.16M

GHRS:

-$40.70M

Returns By Period


SEEL

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

GHRS

YTD

27.59%

1M

-21.86%

6M

-38.13%

1Y

28.92%

5Y*

N/A

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SEEL vs. GHRS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Seelos Therapeutics, Inc. (SEEL) and GH Research PLC (GHRS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SEEL, currently valued at -0.63, compared to the broader market-4.00-2.000.002.00-0.630.59
The chart of Sortino ratio for SEEL, currently valued at -4.26, compared to the broader market-4.00-2.000.002.004.00-4.261.23
The chart of Omega ratio for SEEL, currently valued at 0.53, compared to the broader market0.501.001.502.000.531.15
The chart of Calmar ratio for SEEL, currently valued at -1.00, compared to the broader market0.002.004.006.00-1.000.50
The chart of Martin ratio for SEEL, currently valued at -1.20, compared to the broader market0.0010.0020.00-1.201.47
SEEL
GHRS


Rolling 12-month Sharpe Ratio-0.500.000.501.00JulyAugustSeptemberOctoberNovemberDecember
-0.63
0.59
SEEL
GHRS

Dividends

SEEL vs. GHRS - Dividend Comparison

Neither SEEL nor GHRS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SEEL vs. GHRS - Drawdown Comparison


-100.00%-90.00%-80.00%-70.00%-60.00%JulyAugustSeptemberOctoberNovemberDecember
-100.00%
-73.48%
SEEL
GHRS

Volatility

SEEL vs. GHRS - Volatility Comparison

The current volatility for Seelos Therapeutics, Inc. (SEEL) is 0.00%, while GH Research PLC (GHRS) has a volatility of 28.91%. This indicates that SEEL experiences smaller price fluctuations and is considered to be less risky than GHRS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%JulyAugustSeptemberOctoberNovemberDecember0
28.91%
SEEL
GHRS

Financials

SEEL vs. GHRS - Financials Comparison

This section allows you to compare key financial metrics between Seelos Therapeutics, Inc. and GH Research PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab